Schedule 13G ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,892,256
- Percent of class
- 13.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000138
- Form type
- SC 13G
- Filer
- PhaseBio Pharmaceuticals Inc
- CIK
- CIK 1169245
- Filed
- Jan 27, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership